Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Apr;45(4):559–564. doi: 10.1038/bjc.1982.92

Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.

V J Richardson, G A Curt, B E Ryman
PMCID: PMC2010996  PMID: 7073946

Abstract

Two cell lines, one sensitive and one resistant to the cytotoxic effects of cytosine arabinoside (AraC) were studied in vitro as a drug-resistance model. The sensitivity of these cell lines, to the effects of free and liposomally trapped AraC and AraCTP as well as empty liposomes alone and mixed with free drug, was studied. This was done by following the inhibition of [3H]-dT incorporation into cellular DNA during exposure to the various drugs and liposomes. Some of the liposomal-lipid compositions inhibited [3H]-dT incorporation at very low concentrations, which made them unsuitable for further study. Liposomes composed of a 7:2:1 molar ratio of phosphatidylcholine:cholesterol:phosphatidic acid were selected as a suitable non-inhibitory carrier. Sensitivity of the two cell lines to free AraC differed by 3 logs, when compared in the [3H]-dT-incorporation assay. The resistant cell line was studied further, and was found to be up to 2 logs more sensitive to AraCTP when given in liposomes than to either the free drug alone or mixed with empty liposomes. It appears from these studies that liposomes are able to help overcome drug resistance in this cell line in vitro.

Full text

PDF
559

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Joyce G., Richardson V. J., Ryman B. E., Wiśniewski H. M. Liposome toxicity in the mouse central nervous system. J Neurol Sci. 1977 Mar;31(2):173–179. doi: 10.1016/0022-510x(77)90104-6. [DOI] [PubMed] [Google Scholar]
  2. Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965 Aug;13(1):238–252. doi: 10.1016/s0022-2836(65)80093-6. [DOI] [PubMed] [Google Scholar]
  3. Bruni A., Toffano G., Leon A., Boarato E. Pharmacological effects of phosphatidylserine liposomes. Nature. 1976 Mar 25;260(5549):331–333. doi: 10.1038/260331a0. [DOI] [PubMed] [Google Scholar]
  4. Chou T. C., Hutchinson D. J., Schmid F. A., Philips F. S. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo. Cancer Res. 1975 Jan;35(1):225–236. [PubMed] [Google Scholar]
  5. Coleman C. N., Johns D. G., Chabner B. A. Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells. Ann N Y Acad Sci. 1975 Aug 8;255:247–251. doi: 10.1111/j.1749-6632.1975.tb29231.x. [DOI] [PubMed] [Google Scholar]
  6. Curt G. A., Tobias J. S., Kramer R. A., Rosowsky A., Parker L. M., Tattersall M. H. Inhibition of nucleic acid synthesis by the di-n-butyl ester of methotrexate. Biochem Pharmacol. 1976 Sep 1;25(17):1943–1946. doi: 10.1016/0006-2952(76)90047-2. [DOI] [PubMed] [Google Scholar]
  7. DAWSON R. M. Studies on the hydrolysis of lecithin by a Penicillium notatum phospholipase B preparation. Biochem J. 1958 Dec;70(4):559–570. doi: 10.1042/bj0700559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ganapathi R., Krishan A., Wodinsky I., Zubrod C. G., Lesko L. J. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo. Cancer Res. 1980 Mar;40(3):630–633. [PubMed] [Google Scholar]
  9. Kaye S. B., Boden J. A., Ryman B. E. The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours. Eur J Cancer. 1981 Mar;17(3):279–289. doi: 10.1016/0014-2964(81)90119-5. [DOI] [PubMed] [Google Scholar]
  10. Kaye S. B., Richardson V. J. Potential of liposomes as drug-carriers in cancer chemotherapy: a review. Cancer Chemother Pharmacol. 1979;3(2):81–85. doi: 10.1007/BF00254977. [DOI] [PubMed] [Google Scholar]
  11. Layton D., Luckenbach G. A., Andreesen R., Munder P. G. The interaction of liposomes with cells: the relation of cell specific toxicity to lipid composition. Eur J Cancer. 1980 Dec;16(12):1529–1538. doi: 10.1016/0014-2964(80)90025-0. [DOI] [PubMed] [Google Scholar]
  12. Mulder J. H., Harrap K. R. Cytosine arabinoside uptake by tumour cells in vitro. Eur J Cancer. 1975 May;11(5):373–379. doi: 10.1016/0014-2964(75)90066-3. [DOI] [PubMed] [Google Scholar]
  13. Papahadjopoulos D., Poste G., Vail W. J., Biedler J. L. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells. Cancer Res. 1976 Sep;36(9 PT1):2988–2994. [PubMed] [Google Scholar]
  14. Rustum Y. M., Dave C., Mayhew E., Papahadjopoulos D. Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia. Cancer Res. 1979 Apr;39(4):1390–1395. [PubMed] [Google Scholar]
  15. Rustum Y. M., Mayhew E., Szoka F., Campbell J. Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells. Eur J Cancer Clin Oncol. 1981 Jul;17(7):809–817. doi: 10.1016/0014-2964(81)90237-1. [DOI] [PubMed] [Google Scholar]
  16. Steger L. D., Desnick R. J. Enzyme therapy. VI: Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes. Biochim Biophys Acta. 1977 Feb 4;464(3):530–546. doi: 10.1016/0005-2736(77)90028-1. [DOI] [PubMed] [Google Scholar]
  17. Tattersall M. H., Ganeshaguru K., Hoffbrand A. V. Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol. 1974 May;27(1):39–46. doi: 10.1111/j.1365-2141.1974.tb06772.x. [DOI] [PubMed] [Google Scholar]
  18. Tyrrell D. A., Richardson V. J., Ryman B. E. The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver. Biochim Biophys Acta. 1977 Apr 27;497(2):469–480. doi: 10.1016/0304-4165(77)90204-5. [DOI] [PubMed] [Google Scholar]
  19. de Barsy T., Devos P., Van Hoof F. A morphologic and biochemical study of the fate of antibody-bearing liposomes. Lab Invest. 1976 Mar;34(3):273–282. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES